Navigation Links
Few High-Quality Studies on Food Allergies, Say Reviewers
Date:5/11/2010

No uniform standards for diagnosing a food allergy even exist, researchers find

TUESDAY, May 11 (HealthDay News) -- There's a lack of consistent information about the prevalence, diagnosis and treatment of food allergies, according to researchers who reviewed data from 72 studies.

The articles looked at allergies to cow's milk, hen's eggs, peanuts, tree nuts, fish and shellfish, which account for more than 50 percent of all food allergies.

The review authors found that food allergies affect between 1 percent and 10 percent of the U.S. population, but it's not clear whether the prevalence of food allergies is increasing.

While food challenges, skin-prick testing and blood-serum testing for IgE antibodies to specific foods (immunoglobulin E allergy testing) all have a role to play in diagnosing food allergies, no one test has sufficient ease of use or sensitivity or specificity to be recommended over other tests, Dr. Jennifer J. Schneider Chafen, of the VA Palo Alto Healthcare System and Stanford University School of Medicine, and colleagues, said in a news release.

Elimination diets are a mainstay of food allergy therapy, but the researchers identified only one randomized controlled trial (RCT) -- the gold-standard of evidence -- of an elimination diet.

"Many authorities would consider RCTs of elimination diets for serious life-threatening food allergy reactions unnecessary and unethical; however, it should be recognized that such studies are generally lacking for other potential food [allergy] conditions," the researchers wrote.

In addition, there's inadequate research on immunotherapy, the use of hydrolyzed formula to prevent cow's milk allergy in high-risk infants, or the use of probiotics (beneficial bacteria) in conjunction with breast-feeding or hypoallergenic formula to prevent food allergy, according to the report published in the May 12 issue of the Journal of the American
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Physician Assistants Call on Congress for Policies That Promote High-Quality Patient Care
2. Stomach Acid Drugs Come with Dangers, Studies Show
3. Sponsoring by the pharmaceutical industry can bias the results of drug studies
4. New studies examine adverse outcomes associated with obesity and more applicable measures of obesity
5. Studies Confirm Link Between Breast Density and Cancer
6. New UCSF Studies Reveal that Age-Related Nerve Decline is Associated with Inflammation and Differs by Gender
7. Recent Studies Show MAstertuck℠ Technique Removes Large Amounts of Body Fat without Tummy Tuck Surgery
8. 14 Human Clinical Studies Prove the Efficacy of Tahitian Noni Bioactive Beverages
9. Targeted agent blocked growth of deadly brain cancer in preclinical studies
10. Many Kids Not Fully Informed of Their Role in Cancer Studies
11. Kineta Awarded NIH Grant to Complete Preclinical Studies on Type 1 Diabetes / Multiple Sclerosis Drug Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... For Dr. Iris Hunter, a job is more than just ... life’s mission. Her extensive experience in the nonprofit sector, coupled ... make it clear that Hunter’s mission is to serve others. ... a difference in the lives of others,” Hunter said. “Additionally, ... I felt ready to start on this journey as a ...
(Date:10/22/2014)... (HealthDay News) -- The United States is now ... nations of West Africa land at one of ... with the virus. In a statement released ... 94 percent of air passengers from Guinea, Liberia ... these five airports -- New York City,s Kennedy ...
(Date:10/22/2014)... Va. (PRWEB) October 22, 2014 ... Innovation , which is dedicated to distribute health ... of healthcare delivery worldwide announced the development of ... which patients expect when receiving healthcare. These are ... for patient-centered care: “providing care that is respectful ...
(Date:10/22/2014)... 22, 2014 With the Affordable Care Act ... by the American Institutes for Research (AIR) finds that three ... use health insurance, but 42 percent say they are not ... before signing up for coverage. , The AIR survey found ... percent able to calculate correctly how much they owe for ...
(Date:10/22/2014)... Best Cheap Hosting USA is among the ... has recently announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is ... around the world. , “iPower is one of the ... providing various kinds of useful products for new and ... excellent customer service and a number of features which ...
Breaking Medicine News(10 mins):Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2
... Even while their blood pressures are still normal, overweight ... known to increase pressures as well as early signs ... Georgia researchers looking at 126 healthy 15- to17-year-olds in ... highest among the overweight males. Early intervention could help ...
... form of childhood epilepsy called infantile spasms have developed ... closely resembling those occurring in patients with infantile seizures. ... scientists to test treatments that may benefit children. ... a seizure. Many of them go on to have ...
... Annuity offers a simplified solution to generating lifetime income ... , - Simple A share structure , , ... of a new retirement income product designed to bring the ... the reach of traditional variable annuities. The new product, John ...
... Products Earn Mention in New Stop Growing Older ... Grow ... his just released book "Stop Growing Older ... Grow Younger," ... the multi-billion-dollar anti-aging industry. Throughout the pages of this resource, ... advocating instead an all-natural approach to slowing down the aging ...
... 1 Abbott will present at the Goldman Sachs 30th ... D. White, chairman and chief executive officer, and Thomas C. ... make a presentation on the company at 9:20 a.m. Central ... presentation will be accessible through Abbott,s Investor Relations Web site ...
... standard chemotherapy, an international Phase III trial has shown ... for patients with advanced non-small cell lung cancer, according ... Anderson Cancer Center. The findings, presented today at ... the first clinical benefit of a small molecule targeted ...
Cached Medicine News:Health News:Overweight male teens with normal blood pressures showing signs of heart damage 2Health News:Overweight male teens with normal blood pressures showing signs of heart damage 3Health News:Findings in epilepsy gene in animals may guide treatment directions for infants 2Health News:Findings in epilepsy gene in animals may guide treatment directions for infants 3Health News:John Hancock Launches New Retirement Income Solution 2Health News:John Hancock Launches New Retirement Income Solution 3Health News:John Hancock Launches New Retirement Income Solution 4Health News:John Hancock Launches New Retirement Income Solution 5Health News:Explorer's Bounty Coffees and Chocolates Helping Individuals Reverse the Aging Process 2Health News:Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 2Health News:Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 3
(Date:10/22/2014)... , Oct. 22, 2014  Regulus ... a biopharmaceutical company leading the discovery and ... announced that it has demonstrated human proof-of-concept ... clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated ... of hepatitis C virus infection ("HCV").  Interim ...
(Date:10/20/2014)... MOUNTAIN VIEW, Calif. , Oct. 20, 2014 /PRNewswire/ ... field of interventional pulmonology, today announced completion of enrollment ... schedule.  The RENEW Clinical Study is the FDA-approved IDE ... treatment for severe emphysema. It was anticipated ... US in February 2013, would take until the end ...
(Date:10/20/2014)... 20, 2014  Indianapolis interventional medical device maker ... -based 3D visualization leader Synaptive Medical ... Surgeons Annual Meeting that they have joined forces ... The collaboration is the first of its kind ... patient outcomes. NICO,s BrainPath® interventional access technology and ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5
... June 4 After three long years of ... of Phoebe Sumter Medical Center welcomed the arrival of a ... Siemens Healthcare. The new MRI scanner premiered today at the ... destroyed the hospital in 2007. State and local political dignitaries ...
... Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary ... and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) ... version of Pfizer,s Neurontin® Tablets for the treatment of postherpetic neuralgia, ... Pharmaceuticals Inc. , , ...
Cached Medicine Technology:Siemens Donates MRI Scanner to Help Rebuild Phoebe Sumter Medical Center 2Siemens Donates MRI Scanner to Help Rebuild Phoebe Sumter Medical Center 3Mylan Receives Approval for Generic Version of Neurontin® Tablets 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: